Literature DB >> 12210862

Secondary paroxysmal dyskinesias.

Jaishri Blakeley1, Joseph Jankovic.   

Abstract

Paroxysmal dyskinesias (PxDs) are involuntary, episodic movements that include paroxysmal kinesigenic (PKD), paroxysmal nonkinesigenic (PNKD), and paroxysmal hypnogenic (PHD) varieties. Although most PxDs are primary (idiopathic or genetic), we found 17 of our 76 patients with PxD (22%) to have an identifiable cause for their PxD (10 men; mean age, 41.4 years). Causes included peripheral trauma (in three patients), vascular lesions (in four), central trauma (in four), kernicterus (in two), multiple sclerosis (in one), cytomegalovirus encephalitis (in one), meningovascular syphilis (in one), and migraine (in one). The latency from insult to symptom onset ranged from days (trauma) to 18 years (kernicterus), with a mean of 3 years. Nine patients had PNKD, two had PKD, five had mixed PKD/PNKD, and one had PHD. Hemidystonia was the most common expression of the paroxysmal movement disorder, present in 11 patients. Both of the patients with PKD had symptom durations of <5 minutes. Symptom duration ranged from 10 seconds to 15 days for PNKD and from 5 minutes to 45 minutes for mixed PKD/PNKD. There were no uniformly effective therapies, but anticonvulsant drugs, clonazepam, and botulinum toxin injections were the most beneficial. Awareness of the variable phenomenology and the spectrum of causes associated with secondary PxD will allow for more timely diagnosis and early intervention. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 12210862     DOI: 10.1002/mds.10178

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

1.  Symptomatic paroxysmal kinesigenic choreoathetosis as primary manifestation of multiple sclerosis.

Authors:  Simone Zittel; Maxim Bester; Christian Gerloff; Alexander Münchau; Frank Leypoldt
Journal:  J Neurol       Date:  2011-07-30       Impact factor: 4.849

2.  X-linked paroxysmal dyskinesia and severe global retardation caused by defective MCT8 gene.

Authors:  Knut Brockmann; Alexandra M Dumitrescu; Thomas T Best; Folker Hanefeld; Samuel Refetoff
Journal:  J Neurol       Date:  2005-04-18       Impact factor: 4.849

3.  Treatment of paroxysmal dyskinesias in children.

Authors:  Jonathan W Mink
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

4.  Paroxysmal Kinesigenic Dyskinesia as the Presenting and Only Manifestation of Multiple Sclerosis after Eighteen Months of Follow-Up.

Authors:  Marius Baguma; Michel Ossemann
Journal:  J Mov Disord       Date:  2017-03-24

5.  Stretching the limbs? Tonic spasms in multiple sclerosis.

Authors:  Carlos Andrade; João Massano; Joana Guimarães; Maria Carolina Garrett
Journal:  BMJ Case Rep       Date:  2012-11-30

Review 6.  Psychogenic movement disorders: diagnosis and management.

Authors:  Madhavi Thomas; Joseph Jankovic
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 7.  Episodic movement disorders: from phenotype to genotype and back.

Authors:  Knut Brockmann
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

Review 8.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 9.  Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes.

Authors:  Victor S C Fung; H A Jinnah; Kailash Bhatia; Marie Vidailhet
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

10.  Paroxysmal dyskinesias.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.